Results 301 to 310 of about 196,344 (323)
Some of the next articles are maybe not open access.

Late-onset Stevens–Johnson syndrome due to nivolumab use for hepatocellular carcinoma

Journal of Oncology Pharmacy Practice, 2019
Nivolumab is a fully human immunoglobulin G4 immune checkpoint inhibitor antibody approved for use in the treatment of several malignancies. Severe side effects such as Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) have only extremely ...
C. Dasanu
semanticscholar   +1 more source

Conjunctival Pigmentation in Stevens-Johnson Syndrome

Annals of Ophthalmology, 2007
We report a 29-year-old white woman with conjunctival pigmentation after a Stevens-Johnson syndrome (SJS) episode triggered by sulfasalazine. The patient developed bilateral tarsal and forniceal conjunctiva and black pigmentation. Diagnostic biopsy showed stromal monocyte infiltration consistent with chronic phase SJS and conjunctival pigment of ...
MC Méndez   +5 more
openaire   +5 more sources

Stevens-Johnson syndrome in children

The Pediatric Infectious Disease Journal, 1982
During a 22-year period 51 cases of Stevens-Johnson syndrome (SJS) occurred in infants and children who ranged in age from 3 months to 14 years. Fifty-six percent of patients had an antecedent upper respiratory tract infection or non-specific viral infection, and 67% had received a prescription medication in the 3 weeks before onset of SJS.
openaire   +3 more sources

Accuracy of SCORTEN to predict the prognosis of Stevens‐Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta‐analysis

Journal of the European Academy of Dermatology and Venereology, 2019
The SCORTEN score is a specific predictor of the probability of death for patients diagnosed with Stevens‐Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN).
I. Torres-Navarro   +3 more
semanticscholar   +1 more source

Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!

Indian Journal of Dermatology, 2018
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions, which are mainly caused by drugs; and these are usually associated with high degree of morbidity and mortality.
R. Kumar, Anupam Das, S. Das
semanticscholar   +1 more source

Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Clinical reviews in allergy and immunology, 2018
M. Lerch   +3 more
semanticscholar   +1 more source

STEVENS–JOHNSON SYNDROME

Medical Journal of Australia, 1964
F. R. T. Stevens, C. H. Mok
openaire   +3 more sources

THE STEVENS–JOHNSON SYNDROME

Medical Journal of Australia, 1946
T M Gilbert, S R Hing
openaire   +3 more sources

Home - About - Disclaimer - Privacy